- Home
- NBIX vs SQM Comparison
NBIX vs SQM Comparison
Compare NBIX & SQM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBIX | SQM |
|---|---|---|
| Founded | 1992 | 1968 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 17.6B |
| IPO Year | 1996 | 1993 |
Fundamental Metrics
Financial Performance| Metric | NBIX | SQM |
|---|---|---|
| Price | $151.78 | $65.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 20 | 9 |
| Target Price | ★ $175.10 | $53.39 |
| AVG Volume (30 Days) | 923.0K | ★ 1.9M |
| Earning Date | 10-28-2025 | 11-18-2025 |
| Dividend Yield | N/A | ★ 3.21% |
| EPS Growth | ★ 12.44 | N/A |
| EPS | ★ 4.19 | 1.84 |
| Revenue | $2,682,700,000.00 | ★ $4,326,111,000.00 |
| Revenue This Year | $23.76 | N/A |
| Revenue Next Year | $18.01 | $22.11 |
| P/E Ratio | $36.44 | ★ $35.41 |
| Revenue Growth | ★ 19.61 | N/A |
| 52 Week Low | $84.23 | $29.36 |
| 52 Week High | $160.18 | $66.18 |
Technical Indicators
Market Signals| Indicator | NBIX | SQM |
|---|---|---|
| Relative Strength Index (RSI) | 57.42 | 68.64 |
| Support Level | $151.59 | $59.46 |
| Resistance Level | $156.70 | $62.72 |
| Average True Range (ATR) | 4.18 | 2.05 |
| MACD | 0.35 | -0.20 |
| Stochastic Oscillator | 64.51 | 94.92 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About SQM Sociedad Quimica y Minera S.A.
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM also sells lithium concentrate from a joint venture hard rock lithium project in Australia and expanding its lithium refining assets in China.